VANCOUVER, Aug. 2, 2017 /CNW/ - Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A) ("Isodiol"or the "Company") is pleased to announce that the Financial Industry Regulatory Authority, Inc. ("FINRA") has approved the Company's OTC voluntary symbol change from "LAGBF" to "ISOLF" to better reflect the Company's current name.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for Hemp-derived cannabinoids, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
"Marcos Agramont"CEO & Director
Join Us On Facebook: https://www.facebook.com/isodiol/
The CSE has not reviewed, approved or disapproved the content of this press release.
SOURCE Isodiol International Inc.
Subscribe to our Free Newsletters!
Learn the basics about diabetes and how to bring it under control with turmeric, an highly ...
Antioxidants are artificial or natural components that help protect the human body from the damage ...
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...View All